Clearside Biomedical, Inc.
CLSD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $62,275 | $70,614 | $72,058 |
| - Cash | $6,801 | $9,376 | $13,628 | $20,020 |
| + Debt | $62 | $533 | $54,059 | $52,470 |
| Enterprise Value | – | $53,432 | $111,045 | $104,508 |
| Revenue | $201 | $492 | $2,330 | $306 |
| % Growth | -59.1% | -78.9% | 661.4% | – |
| Gross Profit | $201 | $408 | $2,082 | $157 |
| % Margin | 100% | 82.9% | 89.4% | 51.3% |
| EBITDA | -$3,318 | -$1,649 | -$4,750 | -$4,648 |
| % Margin | -1,650.7% | -335.2% | -203.9% | -1,519% |
| Net Income | -$5,972 | -$4,495 | -$8,223 | -$7,306 |
| % Margin | -2,971.1% | -913.6% | -352.9% | -2,387.6% |
| EPS Diluted | -1.14 | -0.87 | -1.65 | -1.445 |
| % Growth | -31% | 47.3% | -14.2% | – |
| Operating Cash Flow | -$5,480 | -$4,729 | -$5,830 | -$5,254 |
| Capital Expenditures | $0 | $0 | -$9 | -$444 |
| Free Cash Flow | -$5,480 | -$4,729 | -$5,830 | -$5,698 |